Skip to content

Posts from the ‘Posts’ Category

Do ‘Havana Syndrome’ and Gulf War Illness Share Neuroinflammation as a Common Disease Mechanism? on July 12, 2022

Intravenous isosorbide dinitrate will be presented next week as an investigational new drug candidate to treat COVID-19 at the Virginia Drug Discovery Consortium’s annual meeting VaDDRx 2022 in Richmond, Virginia. on May 17, 2022

Can Isosorbide Dinitrate Save Lives of Hospitalized COVID Patients with Hypertension and a Defined Cardiac Injury? on December 31, 2021

Update on the Spike Ferritin Nanoparticle (SpFN) COVID-19 Vaccine Clinical Trial at the Walter Reed Army Institute of Research on December 24, 2021

Walter Reed Army Institute of Research seeks non-military volunteers for a new experimental COVID-19 vaccine on April 8, 2021

Clinical Trial Design to Test Isosorbide Dinitrate as an Anti-Viral Treatment for COVID-19 on March 8, 2021

Mission Statement Clarification on February 7, 2021

DARPA announces research program “ElectRx” as part of the BRAIN Initiative contribution to better Veterans’ post deployment health. on August 28, 2014

DARPA announces SUBNETS on October 26, 2013

Enzastaurin prevents BBB Dysfunction in Mouse Multiple Sclerosis Model through Inhibition of Protein Kinase C on October 5, 2013